Michael F. Para

Michael F. Para's work focuses on clinical research into HIV/AIDS treatment, including studies of antiretroviral drug regimens, immune-modulating agents (such as Toll-like Receptor 7 agonists), and strategies aimed at reducing the latent HIV reservoir in the body. Much of the research involves clinical trials evaluating drug safety, effectiveness, and viral load outcomes in people living with HIV, including how treatment interruptions and genetic factors affect viral rebound. This research is largely collaborative, appearing as part of multi-site clinical trial networks such as the AIDS Clinical Trials Group (ACTG).

Publication output has been uneven over the last decade, with a notable spike in 2020 followed by sparse activity in most other years, indicating an irregular rather than steadily growing or declining pattern.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026